1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Sysnav: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Study of SRP-4053 in DMD Patients Placebo, SRP-4053 - Duchenne Muscular Dystrophy | Phase 1 / Phase 2 | Completed | Sarepta Therapeutics, Inc. | 39 | 2015-01-13 | 2020-10-19 |
Muscular Dystrophy, Duchenne (1)
France (1) · Italy (1) · United Kingdom (1) · United States (1)